Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  34 results for ""Rheumatism--Treatment""

Your Filters

Subject : infliximab
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effectiveness and Safety of Switching from Innovator Infliximab to Biosimilar CT-P13 in Inflammatory Rheumatic Diseases: A Real-World Case Study.

Subjects: *RHEUMATISM treatment; *INFLIXIMAB; *DRUG efficacy

  • Source: Drugs in R&D. Sep2017, Vol. 17 Issue 3, p481-485. 5p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Therapeutic drug monitoring (TDM) as a tool in the switch from infliximab innovator to biosimilar in rheumatic patients: results of a 12-month observational prospective cohort study.

Subjects: DRUG monitoring; INFLIXIMAB; RHEUMATISM treatment

  • Source: Clinical Rheumatology; Sep2017, Vol. 36 Issue 9, p2129-2134, 6p

Record details

Read More Add to Saved list
×
Academic Journal

Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm.

Subjects: EVALUATION of clinical trials; RHEUMATISM treatment; INFLIXIMAB

  • Source: Rheumatology; 2017 Supplement, Vol. 56, piv30-iv48, 19p, 1 Diagram, 7 Charts, 1 Graph

Record details

Read More Add to Saved list
×
Academic Journal

Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?

Subjects: INFLIXIMAB; RHEUMATISM treatment; ANTIRHEUMATIC agents

  • Source: Analytical & Bioanalytical Chemistry; Feb2017, Vol. 409 Issue 5, p1195-1205, 11p

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Biosimilars in rheumatic diseases: structural and functional variability that may impact clinical and regulatory decisions.

Subjects: BIOTHERAPY; RHEUMATISM treatment; MEDICAL decision making

  • Source: Clinical Rheumatology; Dec2016, Vol. 35 Issue 12, p2869-2875, 7p

Record details

Read More Add to Saved list
×
Academic Journal

Biosimilar DMARDs: What Does the Future Hold?

Subjects: RHEUMATISM treatment; THERAPEUTIC use of monoclonal antibodies; ANTIRHEUMATIC agents

  • Source: Drugs; Apr2016, Vol. 76 Issue 6, p629-637, 9p

Record details

Read More Add to Saved list
×
Academic Journal

Is dosage reduction appropriate in patients who respond well to anti-TNF-alpha agents?

Subjects: *RHEUMATISM treatment; *ANTIRHEUMATIC agents; *DOSE-effect relationship in pharmacology

  • Source: Joint Bone Spine. Jul2004, Vol. 71 Issue 4, p257-260. 4p.

Record details

Read More Add to Saved list
×
Academic Journal

Anti-TNF-α Treatment: A Possible Promoter in Endogenous Uveitis? Observational Report on Six Patients: Occurrence of Uveitis Following Etanercept Treatment.

Subjects: *RHEUMATISM treatment; *UVEITIS; *INFLIXIMAB

  • Source: Current Eye Research. Aug2010, Vol. 35 Issue 8, p751-756. 6p. 1 Color Photograph, 1 Black and White Photograph, 1 Chart.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: An open, randomized, controlled trial.

Subjects: RHEUMATISM treatment; METHOTREXATE; HETEROCYCLIC compounds

  • Source: Modern Rheumatology; Jul2014, Vol. 24 Issue 4, p561-566, 6p

Record details

Read More Add to Saved list
×
Academic Journal

INTRA-ARTICULAR INJECTIONS OF INFLIXIMAB IN THE TREATMENT OF INFLAMMATORY RHEUMATIC DISEASES: CASE REPORTS AND REVIEW OF LITERATURE.

Subjects: INFLIXIMAB; ANTIRHEUMATIC agents; RHEUMATISM treatment

  • Source: European Journal of Inflammation; Jan-Apr2010, Vol. 8 Issue 1, p49-54, 6p

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  34 results for ""Rheumatism--Treatment""